Nervgen Pharma NGEN Cash Flow Statement (2025-2026)

NASDAQ NGEN
$1.76 +0.01 (+0.57%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2025 Mar2026
Operating Activities
Net Income (Quarter) -2.75M-1.22M
Share-based Compensation (Quarter) 1.02M0.69M
Gains from Investment Securities (Quarter) -1.39M-4.17M
Asset Writedowns and Impairment (Quarter) 0.00M30.63
Non-cash Items (Quarter) -2.87M-5.98M
Change in Working Capital (Quarter) -2.87M-5.98M
Change in Receivables (Quarter) 0.06M-0.01M
Change in Accured Expenses (Quarter) -0.32M0.91M
Change in Taxes (Quarter) 10.09M12.07M
Other Working Capital Changes (Quarter) -0.02M-0.01M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M
Investing Activities
Divestments (Quarter) 0.02M0.01M
Financing Activities
Other financing activities (Quarter) 0.89M2.03M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 1.14M0.00M
Misc.
Exchange Rate Effect (Quarter) 0.02M-0.07M
Change in Cash (Quarter) -1.95M-4.02M
Beginning Cash Balance (Quarter) 12.03M16.09M